Showing results (251-260 of 285) with videos related to
Sort By:
Pageof 29
Gastroenterology|January 22, 2013
Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosisYujin Hoshida, Augusto Villanueva, Angelo Sangiovanni, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 18, 2013
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma, , , et al.Gastroenterology|March 23, 2011
Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis CJordi Bruix, Thierry Poynard, Massimo Colombo, et al.Journal of Hepatology|September 9, 2014
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovirGeorge V Papatheodoridis, George N Dalekos, Cihan Yurdaydin, et al.Gastroenterology|February 12, 2009
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapyThierry Poynard, Massimo Colombo, Jordi Bruix, et al.Hepatology (Baltimore, Md.)|October 31, 2015
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infectionMaria Antonella Burza, Benedetta Maria Motta, Rosellina Margherita Mancina, et al.Journal of Hepatology|November 9, 2010
FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ programThierry Poynard, Mona Munteanu, Massimo Colombo, et al.The American Journal of Gastroenterology|September 1, 2021
High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal AdherencePhilippe J Zamor, Ashley Brown, Douglas E Dylla, et al.Oncotarget|April 11, 2018
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinomaFarzaneh Moshiri, Alessandro Salvi, Laura Gramantieri, et al.Inflammatory Bowel Diseases|April 2, 2022
Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational StudyGaetano Bergamaschi, Fabiana Castiglione, Renata D'Incà, et al.Pageof 29